These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8402680)

  • 1. Reductive activation of mitomycin C by NADH:cytochrome b5 reductase.
    Hodnick WF; Sartorelli AC
    Cancer Res; 1993 Oct; 53(20):4907-12. PubMed ID: 8402680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation.
    Miura A; Tampo Y; Yonaha M
    Biochem Mol Biol Int; 1995 Sep; 37(1):141-50. PubMed ID: 8653076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
    Mahmutoglu I; Kappus H
    Mol Pharmacol; 1988 Oct; 34(4):578-83. PubMed ID: 2459594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glutathione and ethylxanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumor nuclei.
    Kennedy KA; Mimnaugh EG; Trush MA; Sinha BK
    Cancer Res; 1985 Sep; 45(9):4071-6. PubMed ID: 2411396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and partial characterization of microsomal NADH-cytochrome b5 reductase from higher plant Catharanthus roseus.
    Madyastha KM; Chary NK; Holla R; Karegowdar TB
    Biochem Biophys Res Commun; 1993 Dec; 197(2):518-22. PubMed ID: 8267585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C.
    Suresh Kumar G; Lipman R; Cummings J; Tomasz M
    Biochemistry; 1997 Nov; 36(46):14128-36. PubMed ID: 9369485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
    Marohnic CC; Bewley MC; Barber MJ
    Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal NADH-cytochrome b5 reductase of bovine brain: purification and properties.
    Tamura M; Yubisui T; Takeshita M
    J Biochem; 1983 Nov; 94(5):1547-55. PubMed ID: 6654871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4.
    Celik H; Arinç E
    Xenobiotica; 2013 Mar; 43(3):263-75. PubMed ID: 22928801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction.
    Yang MX; Cederbaum AI
    Arch Biochem Biophys; 1996 Jul; 331(1):69-78. PubMed ID: 8660685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the antineoplastic effect of mitomycin C by dietary fat.
    Shao Y; Pardini L; Pardini RS
    Cancer Res; 1994 Dec; 54(24):6452-7. PubMed ID: 7987842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DT-diaphorase].
    Mikami K; Shirakusa T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1606-10. PubMed ID: 9309161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionation of liver microsomes with polyethylene glycol and purification of NADH-cytochrome b5 oxidoreductase and cytochrome b5.
    Yang MX; Cederbaum AI
    Arch Biochem Biophys; 1994 Dec; 315(2):438-44. PubMed ID: 7986089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of NADH-cytochrome b5 reductase and cytochrome b5 complex in microsomal NADH-cytochrome c reductase activity. Changes in NADH-cytochrome c reductase activity following phenobarbital treatment.
    Starón K; Kaniuga Z
    Acta Biochim Pol; 1974; 21(1):61-6. PubMed ID: 4364831
    [No Abstract]   [Full Text] [Related]  

  • 19. The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    J Biol Chem; 1998 Apr; 273(15):8875-81. PubMed ID: 9535868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mitomycin C by NADPH:cytochrome P-450 reductase.
    Bligh HF; Bartoszek A; Robson CN; Hickson ID; Kasper CB; Beggs JD; Wolf CR
    Cancer Res; 1990 Dec; 50(24):7789-92. PubMed ID: 2123741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.